Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

CIRAMADOL - A NEW SYNTHETIC ANALGESIC - A DOUBLE-BLIND COMPARISON WITH ORAL CODEINE FOR POSTOPERATIVE PAIN RELIEF SOUTH AFRICAN MEDICAL JOURNAL Downing, J. W., BROCKUTNE, J. G., Holloway, A. M. 1983; 64 (25): 978-982

Abstract

One hundred and eighty patients (American Society of Anesthesiologists rating 1-2) received one of three oral analgesics--ciramadol (Wy. 15705) 20 mg, ciramadol 60 mg or codeine 60 mg--on a double-blind random basis for the relief of pain 24-48 hours after major general surgical, gynaecological or orthopaedic operations. All three analgesics proved equally effective and caused mild sedation only. No patient showed signs of clinical cardiorespiratory depression, and other side-effects were infrequent. Ciramadol may therefore prove a useful clinical alternative to conventional oral analgesics provided its lack of respiratory depressant properties and addiction potential in monkeys can be substantiated in humans.

View details for Web of Science ID A1983RV65400016

View details for PubMedID 6359486